Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Sale of 1,103 GH shares, $192.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Guardant Health, Inc. (GH) | Sale | 1,103 | $192.4K |
| Jul 2, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 155 | n/a |
| Jun 22, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 4,203 | n/a |
| Jun 12, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 70,000 | n/a |
| Jun 5, 2026 | Guardant Health, Inc. (GH) | Sale | 9,294 | $1.23M |
| Jun 5, 2026 | Denali Therapeutics Inc. (DNLI) | Grant/Award | 6,408 | n/a |
| Jun 1, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 154 | n/a |
| May 1, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 154 | n/a |
| Apr 1, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 155 | n/a |
| Mar 2, 2026 | Guardant Health, Inc. (GH) | Exercise/Conversion | 154 | n/a |